Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
trans-Chalcone
Cat. No.:
OB0225LY-0018
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
trans-C75, also referred to as (±)-C75, is an enantiomer of C75 and acts as an inhibitor of fatty-acid synthase (FASN), sharing similar biological activities with its counterpart.
Synonym:
Chalcone; Cinnamophenone; 614-47-1; (E)-Chalcone; 2-Propen-1-one, 1,3-diphenyl-; 1-Benzoyl-2-phenylethene
CAS No.:
614-47-1
Compound CID:
637760
Formula:
C15H12O
Formula Weight:
208.26
Specification
Relative Density:
1.097 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
trans-C75 is a synthetic compound that inhibits the enzyme sorbitol dehydrogenase (SDH), which plays a key role in the sorbitol pathway, potentially useful in cancer therapy and metabolic diseases.
Library Information
Targets:
Metabolic enzymes
Receptors:
Fatty acid synthase
Pathways:
Metabolism; Apoptosis; Microbiology/Virology
Plate Number:
AOCL-1
Plate Location:
b9
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
70 mg/mL; 336.12 mM
